Published in:
01-12-2010 | Short communication
Deciding priorities in a clinical studies group
Published in: Breast Cancer Research | Special Issue 4/2010
Login to get accessExcerpt
A Breast Clinical Studies Group seeks to support the initiation, development, recruitment to and reporting of clinical studies and randomised controlled trials. In the United Kingdom, the National Cancer Research Institute (NCRI) Breast Cancer Clinical Studies Group serves these functions (Figure 1).
Figure 1
Structure and interaction of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group. BIDD, Biomarkers and Imaging Discovery and Development Committee; CTACC, Clinical Trials Advisory and Awards Committee; EORTC, European Organisation for Research and Treatment of Cancer; HTA, Health Technology Assessment; IBCSG, International Breast Cancer Study Group; ITAC, Industry Trials Adoption Committee.
× ![]()
…